About URUS TRADE
About URUS TRADE
URUS TRADE is a forex and CFD broker that began operations in November 2020. Despite a registration in France, the company is officially domiciled in Saint Vincent and the Grenadines, a jurisdiction known for minimal financial oversight. The broker primarily markets itself to retail traders seeking high-leverage trading opportunities across a range of asset classes.
Our assessment draws on limited public information, as the broker does not appear to maintain a substantive website or disclose detailed operational data. The absence of a verifiable track record is a significant concern for any prospective trader.
Regulation and Safety
Our review has found that URUS TRADE does not hold any valid regulatory licence from a credible financial authority. The broker has been publicly listed as fraudulent by the Comisión Nacional del Mercado de Valores (CNMV), Spain’s financial regulator.
This absence of regulatory oversight means that traders have no recourse to compensation schemes or dispute resolution mechanisms in the event of malpractice. The broker's presence is limited to a Facebook page, with no evidence of a substantive corporate presence or audited financial disclosures.
Given the CNMV warning and the unregulated status, FXCanary categorises URUS TRADE as a severely high-risk broker. Traders are strongly advised to avoid depositing funds with any entity that cannot demonstrate a valid regulatory licence.
Trading Instruments and Leverage
According to aggregated industry data, URUS TRADE offers five types of trading instruments. Specific asset classes are not detailed in available records, but the broker is known to provide leverage up to 1:1000, which is extremely high and amplifies both potential gains and losses.
Such leverage levels are typically prohibited by regulated brokers and signal a high-risk trading environment. The lack of transparency regarding the instruments themselves further compounds the risks for traders.
Trading Platforms
The broker supports trading on MetaQuotes technology and specifically offers the MetaTrader 5 (MT5) platform. MT5 is a popular multi-asset platform that provides advanced charting, analytical tools, and automated trading capabilities.
However, the absence of a regulated broker behind the platform raises concerns about the integrity of trade execution and fund security. Traders should be cautious when using any platform offered by an unregulated entity.
Company Background
URUS TRADE was established on 5 November 2020. While its official country of registration is France, the broker’s operations are registered in Saint Vincent and the Grenadines.
The company maintains a Facebook page, but there is little other verifiable information about its management, team, or office locations. This lack of transparency is a common red flag among high-risk brokers and makes it difficult for traders to perform adequate due diligence.
Overview compiled by FXCanary from regulatory records and public data. full URUS TRADE review